Introduction
Multivitamin and multi-nutrient formulations are among the most commonly consumed dietary supplements worldwide, with particular uptake among women of reproductive age, pregnant and breastfeeding individuals, and parents administering them to children. In our experience, the rationale is understandable: pregnancy and childhood are periods of increased nutritional demand, and a multivitamin appears to offer a convenient safety net. However, the evidence base for routine use is more nuanced than marketing suggests. We review the clinical data on safety, efficacy, dosing and quality considerations, with a focus on UK and European guidance.
Pregnancy Safety Evidence
The use of multivitamins during pregnancy has been studied extensively, though most trials focus on individual nutrients rather than complete formulations. A landmark Cochrane review by Haider et al. (2017) examined multiple micronutrient supplementation (MMS) versus iron–folic acid alone in pregnant women. The analysis, which included 19 trials and over 138,000 participants, found that MMS reduced the risk of low birth weight (RR 0.88, 95% CI 0.85–0.91) and small-for-gestational-age births (RR 0.92, 0.86–0.98) compared with iron–folic acid alone (Haider et al. 2017, PMID 28262917). Importantly, no increase in adverse maternal or neonatal outcomes was observed. However, the authors noted that the evidence was primarily from low- and middle-income countries where baseline nutritional status is poorer, limiting generalisability to well-nourished populations.
A more recent systematic review by Oh et al. (2020) focused on prenatal multivitamin use in high-income settings (Oh et al. 2020, PMID 32927912). The authors concluded that while folic acid and vitamin D supplementation are clearly beneficial, the additional value of a full multivitamin over targeted supplementation remains uncertain. In our reading, the key safety concern is vitamin A: preformed retinol in doses above 3,000 µg/day (10,000 IU) is teratogenic. Most prenatal multivitamins contain beta-carotene or limited retinol (typically 400–800 µg), which is considered safe. We advise readers to check labels for retinol content and avoid formulations exceeding 1,500 µg/day during pregnancy.
Traditional use of multivitamins in pregnancy dates back to the mid-20th century, when the first prenatal supplements were introduced in the United States. The rationale was rooted in observations of neural tube defect prevention with folic acid, later confirmed by the MRC Vitamin Study (1991). Today, the UK Department of Health recommends folic acid (400 µg/day) and vitamin D (10 µg/day) for all pregnant women, but does not endorse routine multivitamin use. We concur that a targeted approach is preferable unless dietary intake is inadequate.
Lactation Considerations
During breastfeeding, maternal nutrient demands increase for several vitamins and minerals, particularly iodine, choline, vitamin D and B vitamins. A systematic review by Bravi et al. (2016) examined the impact of maternal supplementation on breast milk composition (Bravi et al. 2016, PMID 27557695). The authors found that maternal intake of vitamin D, iodine and DHA directly influences their concentration in breast milk, while other nutrients like iron and zinc are less affected. For example, maternal vitamin D supplementation of 2,000–4,000 IU/day significantly raises milk vitamin D content, which is relevant for exclusively breastfed infants at risk of deficiency.
We caution against high-dose multivitamins during lactation without clinical indication. Excessive vitamin B6 (pyridoxine) intake, typically above 100 mg/day, has been associated with a theoretical risk of galactorrhoea suppression, though evidence is weak. More practically, many multivitamins contain iron, which can cause gastrointestinal discomfort in some women. The UK National Health Service (NHS) advises that breastfeeding mothers can take a vitamin D supplement (10 µg/day) and consider a general multivitamin if their diet is poor, but emphasises that most nutrients are adequately obtained from a balanced diet.
From a traditional perspective, postpartum tonics containing multivitamins have been used in various cultures to support maternal recovery. However, we find no robust evidence that routine multivitamin use improves lactation outcomes or infant growth in well-nourished populations. Our practice is to recommend targeted supplementation based on individual dietary assessment.
Paediatric Dosing
Paediatric multivitamins are widely marketed for children, yet the evidence for routine use in healthy children is limited. The American Academy of Pediatrics (AAP) states that most children do not need a multivitamin if they eat a varied diet. However, specific populations may benefit: children with restrictive diets (e.g., vegan, elimination diets), those with malabsorptive conditions (coeliac disease, cystic fibrosis), or those with poor appetite.
Dosing in children must be weight-based and age-appropriate. A common formulation for children aged 2–4 years might provide 50–100% of the Reference Nutrient Intake (RNI) for vitamins A, C, D, E and B-complex, with iron at 5–10 mg and zinc at 2–5 mg. We caution against exceeding the Tolerable Upper Intake Level (UL) for any nutrient. For example, vitamin A in children should not exceed 600 µg/day (retinol equivalents) for ages 1–3, and 900 µg/day for ages 4–8. Excess vitamin A can cause hepatotoxicity and bone abnormalities.
A study by Thomas et al. (2020) examined multivitamin use in UK children and found that 23% of parents reported giving supplements, often without medical advice (Thomas et al. 2020, PMID 32473677). The authors noted a risk of excessive intake, particularly of vitamin A and iron, when supplements are combined with fortified foods. We advise parents to consult a healthcare professional before starting any multivitamin in children, and to choose formulations that do not exceed 100% of the RNI for any nutrient.
Why We Err on Caution
Our cautious stance stems from several observations. First, the principle of primum non nocere applies: in well-nourished individuals, multivitamins offer little proven benefit and carry potential risks, including nutrient excess and interactions. Second, the supplement industry is less tightly regulated than pharmaceuticals; quality and label accuracy vary. A 2018 analysis by the UK Medicines and Healthcare products Regulatory Agency (MHRA) found that 12% of tested multivitamins did not meet label claims for at least one nutrient. Third, the long-term effects of high-dose multivitamin use in children are unknown. We prefer to emphasise dietary approaches first.
We also note that many multivitamins contain nutrients with narrow therapeutic windows, such as iron and vitamin A. Accidental overdose in children is a real concern: iron poisoning remains a leading cause of paediatric poisoning deaths. We recommend that all supplements be stored out of reach of children and that parents use only age-appropriate formulations.
Dosage and Quality Considerations
When a multivitamin is indicated, we advise selecting a product that provides nutrients at or near 100% of the RNI for the target population, not megadoses. For pregnancy, a typical formulation might contain: folic acid 400 µg, vitamin D 10 µg, iron 15–30 mg, calcium 200–500 mg, iodine 150 µg, and B vitamins at 100% RNI. For breastfeeding, similar doses are appropriate, with additional choline (200–400 mg) and DHA (200–300 mg) if desired. For children aged 2–12, we prefer chewable or liquid forms with doses per age group as per the UK Department of Health guidelines.
Quality markers include third-party testing by organisations such as USP, NSF International or the UK's MHRA. We look for products that state they are manufactured in GMP-certified facilities and provide a certificate of analysis (COA) for potency and purity. We avoid products with proprietary blends that do not disclose individual nutrient amounts. In the UK, the Food Standards Agency (FSA) regulates supplements under the Food Supplements Regulations 2003; we recommend checking for compliance with these standards.
Drug Interactions and Contraindications
Multivitamins can interact with several medications. The most clinically significant interactions involve vitamin K antagonising warfarin: a sudden increase in vitamin K intake (from a multivitamin containing 25–100 µg) can reduce INR and increase thrombotic risk. We advise patients on warfarin to maintain consistent vitamin K intake and consult their prescriber before starting a multivitamin. Iron can chelate with levothyroxine, reducing its absorption; we recommend separating doses by at least 4 hours. Calcium can interfere with bisphosphonates (e.g., alendronate) and certain antibiotics (e.g., ciprofloxacin, tetracycline). The mechanism is chelation in the gut, reducing drug bioavailability. We advise taking these medications at least 2 hours apart from calcium-containing supplements.
Contraindications include known hypersensitivity to any ingredient, haemochromatosis (iron overload), and hypercalcaemia. In children, multivitamins with iron should be avoided in those with iron overload disorders (e.g., thalassaemia major). We also caution against use in patients with renal impairment, as accumulation of fat-soluble vitamins can occur.
Sourcing and Quality Markers
We prioritise multivitamins that are independently tested for purity and potency. Look for a COA that confirms the absence of heavy metals (lead, arsenic, cadmium, mercury) and microbial contaminants. In the UK, the MHRA operates a Yellow Card Scheme for reporting adverse reactions; we encourage readers to report any suspected side effects. We also note that some multivitamins use synthetic forms of nutrients (e.g., dl-alpha-tocopherol vs. d-alpha-tocopherol for vitamin E); the natural form is more bioavailable. For vitamin B12, cyanocobalamin is stable and well-absorbed, but methylcobalamin may be preferred in certain metabolic conditions.
We recommend purchasing from reputable manufacturers with transparent sourcing. In our experience, products that list the specific chemical form of each nutrient (e.g., ferrous bisglycinate, calcium citrate) tend to have better absorption profiles. Avoid products with excessive fillers, artificial colours or sweeteners, especially for children.
Frequently Asked Questions
- Can I take a multivitamin while pregnant if I already eat well? In our view, targeted supplementation with folic acid and vitamin D is sufficient for most well-nourished women. A multivitamin may be considered if dietary intake is inadequate, but check that vitamin A is not excessive.
- Is it safe to take a multivitamin while breastfeeding? Yes, but choose a formulation designed for lactation with appropriate doses of iodine, choline and vitamin D. Avoid high-dose vitamin B6.
- Should I give my child a multivitamin? Only if recommended by a healthcare professional for a specific deficiency or dietary restriction. Most healthy children do not need one.
- What is the best form of multivitamin for children? Chewable or liquid forms with age-appropriate doses. Avoid gummy vitamins that may contain added sugars and have lower nutrient stability.
- Can a multivitamin interact with my thyroid medication? Yes, iron and calcium can reduce levothyroxine absorption. Take them at least 4 hours apart.
- How do I know if a multivitamin is good quality? Look for third-party testing (USP, NSF), a COA, and GMP certification. Avoid proprietary blends.
Where to try it. If you want to source what we have described in this article, a transparent UK Multivitamin supplier is the option we point readers to. This site is published by Vitadefence Ltd; we disclose that here.